TrialBee is a technology company focused on solving patient recruitment challenges for clinical trials by combining its vendor-agnostic Honey Platform with data-driven outreach and a global network of recruitment experts. The Honey Platform centralizes and standardizes recruitment activities across all channels, offering real-time patient tracking, higher-quality referrals, and ROI reporting for sponsors, CROs, and research sites. Over the past year the company has added sponsor-specific registries, expanded data partnerships, and surpassed 1.5 million patients screened while collaborating with more than 6,000 research sites in 50 countries and 66 languages. TrialBee’s omnichannel approach uses consumer behavior data, hyper-targeted digital marketing, two-step pre-qualification, and site-friendly materials to accelerate enrollment. The company serves global biopharma customers that require predictable, fast, and scalable patient enrollment across therapeutic areas. Proceeds from the new investment will be used to further scale the Honey Platform, deepen analytics capabilities, and broaden international delivery. Headquartered in Malmö, Sweden and Wilmington, Delaware, TrialBee aims to make clinical research accessible to every patient everywhere.

Total raised

$20M

Funding rounds

6

Latest round

Series B

Latest activity

Apr 2020